Table 4.
Antimicrobial regimens for treatment of proven acute bacterial meningitis in the study population.
| Antimicrobial regimen | n (%) |
|---|---|
| Meropenem plus vancomycin | 1 (2.78) |
| Ceftriaxone plus vancomycin | 25 (69.44) |
| Ceftriaxone plus vancomycin plus ampicillin | 4 (11.11) |
| Ceftazidime plus vancomycin plus ampicillin | 2 (5.56) |
| Cefepime plus vancomycin | 2 (5.56) |
| Ceftriaxone | 2 (5.56) |